Date published: 2025-11-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

MTMR6 Inhibitors

MTMR6 inhibitors are a class of chemical compounds that target the enzyme Myotubularin-related protein 6 (MTMR6). MTMR6 belongs to the myotubularin family of phosphatases, which are involved in the regulation of various cellular processes, particularly those related to the control of cellular membranes and lipid metabolism. MTMR6 is predominantly found in the cytoplasm and plays a crucial role in the modulation of phosphoinositide signaling pathways, specifically the dephosphorylation of phosphatidylinositol 3-phosphate (PI3P) and phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2). These phosphoinositides are essential for the regulation of membrane trafficking, endocytosis, autophagy, and vesicular transport within cells. MTMR6 inhibitors are designed to selectively interfere with the activity of MTMR6, thereby altering the balance of phosphoinositides in cells. By inhibiting MTMR6, these compounds can potentially impact various cellular processes associated with phosphoinositide signaling, ultimately leading to diverse biological effects. The development and study of MTMR6 inhibitors hold promise for advancing our understanding of the complex regulatory mechanisms governing cellular membrane dynamics and lipid metabolism. Furthermore, they may have applications in research areas such as cell biology, molecular biology, and signal transduction pathways, where manipulating phosphoinositide levels and membrane dynamics is of particular interest for exploring fundamental cellular processes.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Inhibits PI3K, upstream of MTMR6, altering phosphoinositide levels and thereby MTMR6 activity.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

Another PI3K inhibitor, reduces phosphoinositide production affecting MTMR6 function.

Autophagy Inhibitor, 3-MA

5142-23-4sc-205596
sc-205596A
50 mg
500 mg
$56.00
$256.00
113
(3)

Autophagy inhibitor that can alter MTMR6-related signaling by affecting cellular degradation pathways.

Perifosine

157716-52-4sc-364571
sc-364571A
5 mg
10 mg
$184.00
$321.00
1
(2)

Akt inhibitor that can disrupt pathways where MTMR6 is involved, particularly in lipid signaling.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

Inhibits MEK, which may indirectly affect MTMR6's role in downstream signaling pathways.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK inhibitor that could modify cellular processes in which MTMR6 is a participant.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

p38 MAPK inhibitor potentially altering pathways that could involve MTMR6.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

mTOR inhibitor that impacts cellular growth processes that MTMR6 may regulate.

PP 2

172889-27-9sc-202769
sc-202769A
1 mg
5 mg
$92.00
$223.00
30
(1)

Src family kinase inhibitor possibly affecting signaling cascades related to MTMR6's function.

ZM-447439

331771-20-1sc-200696
sc-200696A
1 mg
10 mg
$150.00
$349.00
15
(1)

Aurora kinase inhibitor that could affect cell cycle progression related to MTMR6 activities.